Notice Title

Consent to the Distribution of New Medicines

Publication Date
21 Sep 2023

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2023-go4409
Title
View PDF
File Type and Size
PDF (37 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Alprolix
Active Ingredient: Eftrenonacog alfa 250IU
Dosage Form: Powder for infusion with diluent
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
   
Product: Alprolix
Active Ingredient: Eftrenonacog alfa 500IU
Dosage Form: Powder for infusion with diluent
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
   
Product: Alprolix
Active Ingredient: Eftrenonacog alfa 1000IU
Dosage Form: Powder for infusion with diluent
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
   
Product: Alprolix
Active Ingredient: Eftrenonacog alfa 2000IU
Dosage Form: Powder for infusion with diluent
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
   
Product: Alprolix
Active Ingredient: Eftrenonacog alfa 3000IU
Dosage Form: Powder for infusion with diluent
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
   
Product: Alprolix
Active Ingredient: Eftrenonacog alfa 4000IU
Dosage Form: Powder for infusion with diluent
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
   
Product: NITYR
Active Ingredient: Nitisinone 2mg
Dosage Form: Tablet
New Zealand Sponsor: Orpharma NZ Limited
Manufacturers: Penn Pharmaceutical Services Limited, Tredegar, United Kingdom
Rivopharm SA, Manno, Switzerland
   
Product: NITYR
Active Ingredient: Nitisinone 5mg
Dosage Form: Tablet
New Zealand Sponsor: Orpharma NZ Limited
Manufacturers: Penn Pharmaceutical Services Limited, Tredegar, United Kingdom
Rivopharm SA, Manno, Switzerland
   
Product: NITYR
Active Ingredient: Nitisinone 10mg
Dosage Form: Tablet
New Zealand Sponsor: Orpharma NZ Limited
Manufacturers: Penn Pharmaceutical Services Limited, Tredegar, United Kingdom
Rivopharm SA, Manno, Switzerland


Dated this 18th day of September 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).